Sort by
Refine Your Search
-
REFINE-MS trial, a multi-centre, phase 3 study led by Professor Olga Ciccarelli and Professor Max Parmar at UCL. The trial aims to identify the optimal dosing frequency of ocrelizumab in patients with
-
assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. Our commitment to Equality, Diversity and Inclusion The
Enter an email to receive alerts for professor-"https:"-"https:"-"https:"-"https:"-"https:" "UCL;" positions